Research News and Research

RSS

Taking the final step from the bench to the hospital or clinic bedside

A new Regenstrief Institute and Indiana University Center for Aging Research (IUCAR) study provides effective strategies to help hospital systems, physicians and other care providers to overcome end zone hurdles and actually take evidence-based research to the patient's hospital or clinic bedside.

18 May 2010

Repetitive treatment with cocktail of B vitamins improve recovery after TBI

Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.

18 May 2010

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

The Whittemore Peterson Institute for Neuro-Immune Disease (WPI) and Cerus Corporation announced positive results from a study demonstrating the efficacy of the INTERCEPT Blood System to inactivate XMRV, a human retrovirus, in donated platelet components.

18 May 2010

Senesco to present preclinical data of SNS-01 at ASGCT Annual Meeting

Senesco Technologies, Inc. today announced that preclinical data for the Company's lead drug candidate, SNS-01, will be presented on May 20, 2010 at the American Society of Gene and Cell Therapy Annual Meeting being held at the Marriott Wardman Park Hotel in Washington, D.C. from May 17 to 22.

18 May 2010

Immunetics receives $2.8M contract as part of NHLBI's REDS-II project

Immunetics, Inc. has been selected to receive a $2.8 million contract as part of the National Heart, Lung, and Blood Institute's Retrovirus Epidemiology Donor Study-II project, a long term epidemiologic study of blood safety involving HIV and other infectious and non-infectious complications of blood transfusion.

18 May 2010

Senesco Technologies third-quarter net loss increases to $5.28M

Senesco Technologies, Inc. today announced financial results for the three and nine months ended March 31, 2010.

18 May 2010

Varian Medical Systems launches fully-integrated ProBeam proton therapy system at 2010 PT-COG

Varian Medical Systems is introducing the fully-integrated ProBeam™ proton therapy system at the 2010 Particle Therapy Co-operative Group (PT-COG) meeting here this week. The ProBeam system incorporates imaging, gating, robotic patient positioning, treatment planning and oncology information software to enhance treatment quality for patients and workflow efficiency for clinicians.

18 May 2010

Catalyst Pharmaceutical Partners first-quarter net loss decreases to $0.06 per basic and diluted share

Catalyst Pharmaceutical Partners, Inc. today announced its financial results for the three month period ended March 31, 2010. The Company reported a net loss of $1,045,043, or $0.06 per basic and diluted share, compared to a net loss of $3,031,201, or $0.22 per basic and diluted share, for the same period in 2009.

18 May 2010

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.

18 May 2010

Warnings about a ruined appearance is best way to reduce tanning salon visits

What's the most effective way to convince young women to cut back on their indoor tanning, a habit that hikes their risk of melanoma, the deadliest form of skin cancer, by 75 percent? Warn them that it will cause leathery, wrinkled skin.

18 May 2010

Statue commemorating 30th anniversary of the eradication of smallpox unveiled

A statue commemorating the 30th anniversary of the eradication of smallpox is being unveiled today in front of the World Health Organization headquarters by the Director-General of the World Health Organization, Dr Margaret Chan.

18 May 2010

Interphone Study underestimates risk of brain cancer, says International EMF Collaborative

Authors of the report, "Cellphones and Brain Tumors: 15 Reasons for Concern, Science, Spin and the Truth Behind Interphone" have released a technical analysis of the long-awaited Interphone Study published today in the International Journal of Epidemiology.

18 May 2010

Study looks at the experiences of nurses with euthanasia, other end-of-life decisions

Nurses in Belgium who administer life-ending drugs in euthanasia and in cases without explicit patient request often act outside of the law, according to a study in CMAJ.

18 May 2010

Web conference to analyze latest trends, developments in the European melanoma skin cancer market

There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.

18 May 2010

Tengion reports net loss attributable to common stockholders of $14.33 per share for first-quarter 2010

Tengion Inc. today reported its financial results for the quarter ended March 31, 2010 and provided a corporate and clinical development update.

18 May 2010

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

Human stem cells administered intravenously can restore alveolar epithelial tissue to a normal function in a novel ex vivo perfused human lung after E. coli endotoxin-induced acute lung injury, according to research from the University of California San Francisco.

18 May 2010

Acurian announces opted-in database for minority patient recruitment

Acurian, a leader in clinical trial patient recruitment and retention, announced today that its opted-in patient database is an effective resource for reaching minority populations for patient recruitment. Increasing minority participation is crucial for trial success and regulatory approval, especially for therapies intended to treat diseases with high incidence and prevalence rates among minorities.

18 May 2010

KTH Royal Institute of Technology Stockholm, BioSilta Oy collaborate to optimise protein screening

KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.

18 May 2010

Ion Torrent chairman and CEO named 2010 winner of Connecticut Medal of Technology

Dr. Jonathan M. Rothberg, chairman, CEO and founder of Guilford-based Ion Torrent, has been named the 2010 winner of the Connecticut Medal of Technology for his development of innovative genomic technology.

18 May 2010

Simcere Pharmaceutical first-quarter total revenue up 3.7% to $67.2 million

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended March 31, 2010.

18 May 2010

Research News and Research

Taking the final step from the bench to the hospital or clinic bedside

Repetitive treatment with cocktail of B vitamins improve recovery after TBI

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

Senesco to present preclinical data of SNS-01 at ASGCT Annual Meeting

Immunetics receives $2.8M contract as part of NHLBI's REDS-II project

Senesco Technologies third-quarter net loss increases to $5.28M

Varian Medical Systems launches fully-integrated ProBeam proton therapy system at 2010 PT-COG

Catalyst Pharmaceutical Partners first-quarter net loss decreases to $0.06 per basic and diluted share

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

Warnings about a ruined appearance is best way to reduce tanning salon visits

Statue commemorating 30th anniversary of the eradication of smallpox unveiled

Interphone Study underestimates risk of brain cancer, says International EMF Collaborative

Study looks at the experiences of nurses with euthanasia, other end-of-life decisions

Web conference to analyze latest trends, developments in the European melanoma skin cancer market

Tengion reports net loss attributable to common stockholders of $14.33 per share for first-quarter 2010

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

Acurian announces opted-in database for minority patient recruitment

KTH Royal Institute of Technology Stockholm, BioSilta Oy collaborate to optimise protein screening

Ion Torrent chairman and CEO named 2010 winner of Connecticut Medal of Technology

Simcere Pharmaceutical first-quarter total revenue up 3.7% to $67.2 million

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News